Polycrystalline B-type crystal of alogliptin hydrochloride, preparation method and production purpose thereof

A hydrochloride, crystal technology, applied in the field of crystals of pharmaceutical compounds

Inactive Publication Date: 2015-06-24
湖北华世通生物医药科技有限公司
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Said preparation methods generally lead to dimerized by-products of the g

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polycrystalline B-type crystal of alogliptin hydrochloride, preparation method and production purpose thereof
  • Polycrystalline B-type crystal of alogliptin hydrochloride, preparation method and production purpose thereof
  • Polycrystalline B-type crystal of alogliptin hydrochloride, preparation method and production purpose thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Embodiment 1 Alogliptin reaction solution preparation

[0052]Add 400ml of absolute ethanol into a 1L three-necked reaction flask, stir, and then add 80.5g of 2-(6-chloro-3-methyl-2,4-dioxo-3,4-dihydro-2-H-pyrimidine- 1-ylmethyl)benzonitrile, 53.1g of (R)-3-aminopiperidine dihydrochloride and 68.1g of sodium carbonate, the system was heated up to 75°C for reaction, and the direct raw material reaction was completed.

[0053] After the reaction, the system was cooled to below 40° C., the inorganic salts were removed by filtration, and the filter cake was washed twice with 80 ml of absolute ethanol. Collect the mother liquor for later use (see the attachment for HPLC test results) Figure 4 : 3.8% of the dimerized by-product percentage of general formula (A) is arranged in the mother liquor, and 19.5min is the peak time of the dimerized by-product of general formula (A).

Embodiment 2

[0054] Example 2 Preparation of Polymorph B of Alogliptin Hydrochloride

[0055] Concentrate 112ml of the mother liquor of Example 1 to remove the solvent, add 80.6ml of absolute ethanol to dissolve it, transfer it to a 250ml third-product reaction bottle, stir it magnetically, cool the system to 0-5°C, add 1.5 equivalents of hydrochloric acid dropwise, and control the temperature at 0-5°C. 10°C. After dropping, keep warm at 0-10°C for 1h. Suction filtration, the filter cake was washed twice with 10ml of absolute ethanol, and vacuum-dried at 50-60°C to obtain 17.6g of the polycrystalline type B product of alogliptin hydrochloride (see the attached Figure 5 : In the product, the percentage of dimerized by-products of general formula (A) is ≤0.1%, and 19.5min is the peak time of the dimerized by-products of general formula (A).

Embodiment 3

[0056] Example 3 Preparation of Crystal Form B of Alogliptin Hydrochloride

[0057] Concentrate 56ml of the mother liquor of Example 1 to remove the solvent, add 40.3ml of absolute ethanol to dissolve it, transfer it to a 100ml three-product reaction bottle, stir it magnetically, cool the system to 0-5°C, add 1 equivalent of hydrochloric acid dropwise, and control the temperature at -5 ~0°C. After dropping, keep warm at -5~0℃ for 1h. Suction filtration, the filter cake was washed twice with 10ml of absolute ethanol, and vacuum-dried at 50-60°C to obtain 8.7g of polycrystalline type B product of alogliptin hydrochloride (HPLC test result: there is general formula (A) in the product The percentage of dimerization by-products ≤ 0.1%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a polycrystalline B-type crystal of alogliptin hydrochloride and a preparation method thereof. The polycrystalline B-type crystal is prepared by an x-ray powder diffraction method of Cu-K alpha radiation, and the x-ray powder diffraction comprises peaks with 2 theta being 8.87+/-0.2 degrees, 12.67+/-0.2 degrees, 14.39+/-0.2 degrees, 14.84+/-0.2 degrees, 16.33+/-0.2 degrees, 18.66+/-0.2 degrees, 19.12+/-0.2 degrees, 20.20+/-0.2 degrees, 22.49+/-0.2 degrees, 24.18+/-0.2 degrees, 24.54+/-0.2 degrees, 25.48+/-0.2 degrees, 27.31+/-0.2 degrees, 28.83+/-0.2 degrees, 30.18+/-0.2 degrees, 32.97+/-0.2 degrees, 36.85+/-0.2 degrees and 38.76+/-0.2 degrees. The high-purity crystal obtained can be precipitated out of a system, a dimer by-product in the reaction can be effectively removed, production efficiency is raised, and production cost is reduced.

Description

technical field [0001] The present invention relates to a crystal of a pharmaceutical compound, in particular, the present invention relates to polymorph B of alogliptin hydrochloride, its preparation method and production application. Background technique [0002] Alogliptin benzoate (Alogliptin benzoate) is a serine protease dipeptidyl peptidase IV (DPP-IV) inhibitor developed by Japan's Takeda Company, which can maintain glucagon-like peptide 1 (GLP-1) and glucose dependence in the body. Insulin-promoting polypeptide (GIP) level can promote the secretion of insulin, thereby exerting the hypoglycemic effect. In April 2010, it was approved by the Ministry of Health, Labor and Welfare of Japan. The chemical structure is as follows: [0003] [0004] Molecular formula: C 18 h 21 N 5 o 2 ·C 7 h 6 o 2 Molecular weight: 461.51. Alogliptin chemical name: 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1 (2H)-pyrimidinyl]methyl]benzonitrile. [000...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D401/04
CPCC07D401/04C07B2200/13
Inventor 胡名龙夏艳开崔健
Owner 湖北华世通生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap